erythrosine has been researched along with mitoxantrone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fridborg, H; Killander, A; Kristensen, J; Larsson, R; Liliemark, J; Nygren, P; Oberg, G; Simonsson, B | 1 |
| Elliott, JI; Higgins, CF; Raguz, S | 1 |
| Barrand, MA; Cahn, AP; Cooray, HC; Hladky, SB; Shahi, S; van Veen, HW | 1 |
| Ambudkar, SV; Chearwae, W; Limtrakul, P; Phisalphong, C; Shukla, S | 1 |
| Ee, PL; Go, ML; Han, Y; Riwanto, M | 1 |
| Ee, PL; Go, ML; Lee, CY; Sim, HM | 1 |
| Efferth, T; Eichhorn, T; Korn, B; Paulsen, M; Wiench, B | 1 |
| Capon, RJ; Chen, ZS; Huang, XC; Salim, AA; Talele, TT; Xiao, X; Zhang, YK | 1 |
| Arnold, M; Bissinger, R; Lang, F | 1 |
9 other study(ies) available for erythrosine and mitoxantrone
| Article | Year |
|---|---|
Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Agents; Cladribine; Cytarabine; Daunorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Fluoresceins; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Tumor Cells, Cultured | 1994 |
Multidrug transporter activity in lymphocytes.
Topics: Adrenergic alpha-Antagonists; Aniline Compounds; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; B-Lymphocytes; Calcium Channel Blockers; Fluoresceins; Fluorescent Dyes; Lymphocytes; Mice; Mice, Knockout; Mitoxantrone; Multidrug Resistance-Associated Proteins; Paclitaxel; Prazosin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Verapamil; Xanthenes | 2004 |
Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids.
Topics: Adenosine Triphosphatases; Adrenal Cortex Hormones; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Beclomethasone; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Fluoresceins; Humans; Mitoxantrone; Mometasone Furoate; Neoplasm Proteins; Pregnadienediols; Pregnenediones | 2006 |
Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Topics: Adenosine Triphosphate; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Beryllium; Cell Line, Tumor; Chlorophyll; Curcumin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluoresceins; Fluorescent Dyes; Fluorides; Humans; Mitoxantrone; Molecular Structure; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Rhodamine 123; Vinblastine | 2007 |
Modulation of breast cancer resistance protein (BCRP/ABCG2) by non-basic chalcone analogues.
Topics: Adenosine Triphosphatases; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blotting, Western; Cell Line, Tumor; Cell Survival; Chalcones; DNA, Complementary; DNA, Neoplasm; Female; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mitoxantrone; Neoplasm Proteins | 2008 |
Dimethoxyaurones: Potent inhibitors of ABCG2 (breast cancer resistance protein).
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzofurans; Blotting, Western; Breast Neoplasms; Cell Proliferation; Cell Survival; Crystallography, X-Ray; DNA, Complementary; Dogs; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluoresceins; Humans; Indicators and Reagents; Mitoxantrone; Models, Molecular; Neoplasm Proteins; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2008 |
Utilizing inherent fluorescence of therapeutics to analyze real-time uptake and multi-parametric effector kinetics.
Topics: Antineoplastic Agents; Biological Transport; Camptothecin; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Fluorescence; Humans; Irinotecan; Kinetics; Mitoxantrone; Reactive Oxygen Species; Single-Cell Analysis | 2012 |
Lamellarin O, a pyrrole alkaloid from an Australian marine sponge, Ianthella sp., reverses BCRP mediated drug resistance in cancer cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Australia; Coumarins; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Heterocyclic Compounds, 4 or More Rings; Humans; Isoquinolines; Mitoxantrone; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Porifera; Structure-Activity Relationship | 2014 |
Mitoxantrone-induced suicidal erythrocyte death.
Topics: Acetylcysteine; Annexin A5; Apoptosis; Calcium; Cell Death; Cell Membrane; Cell Size; Ceramides; Erythrocytes; Fluoresceins; Humans; Mitoxantrone; Multiple Sclerosis; Oxidative Stress; Phosphatidylserines; Reactive Oxygen Species | 2014 |